Create a free account and describe your company. With the trial, CanPursue checks every opportunity against it and explains the fit.
Create free accountCreate a free account to see past contracts like this one: who won and at what price.
Create free accountThe objective of the project is to have tests carried out in accordance with Good Manufacturing Practices and current regulations (Health Canada, Food and Drug Administration (FDA), European Medicines Agency (EMA) for the analysis of raw materials, solutions, products, etc., in order to confirm the quality of our products.
The National Research Council of Canada has built a new Clinical Trial Material Facility (CTMF) that will house the process and equipment for the production and the quality control of protein, viral vector or virus- like particle vaccines or biologics. The facility will require being compliant with Canadian Good Manufacturing Practices (GMP) as well as FDA current GMP (cGMP) and Eudralex requirements.
This supply Arrangement includes 3 Streams (1,2,3) of services as follows: Stream 1 – Raw Material Analysis , Stream 2 – Various solutions, Biological products Analysis and Stream 3 – Cell Bank Characterization . See Statement of work for full details.
Not stated in the notice: procurement type, procurement method, selection criteria, region of delivery, region of opportunity, expected contract period, end user
The source reports 2 amendments. CanPursue observed 1 of them with dates.
No attachments listed in the open data.
No contact listed in the open data.